CL King Initiates Coverage On Merit Medical Systems with Buy Rating, Announces Price Target of $88
Portfolio Pulse from Benzinga Newsdesk
CL King analyst Kristen Stewart has initiated coverage on Merit Medical Systems (MMSI) with a Buy rating and set a price target of $88.
April 11, 2024 | 6:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical Systems receives a Buy rating from CL King with a price target of $88, indicating a positive outlook from the analyst.
The initiation of coverage by CL King with a Buy rating and a price target of $88 for Merit Medical Systems suggests a strong confidence in the company's future performance. This positive analyst outlook can lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100